Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | BRS3 | P32247 | 2/20 | 0.53 |
| ▸ | ATP4A | P20648 | 6/20 | 0.51 |
| ▸ | ATP4B | P51164 | 6/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | ATP1A1 | P05023 | 5/20 | 0.51 |
| ▸ | ATP1B1 | P05026 | 5/20 | 0.51 |
| ▸ | ATP1A3 | P13637 | 5/20 | 0.51 |
| ▸ | ATP1B2 | P14415 | 5/20 | 0.51 |
| ▸ | ATP1A2 | P50993 | 5/20 | 0.51 |
| ▸ | ATP1B3 | P54709 | 5/20 | 0.51 |
| ▸ | FXYD2 | P54710 | 5/20 | 0.51 |
| ▸ | ATP1A4 | Q13733 | 5/20 | 0.51 |
| ▸ | WDR5 | P61964 | 3/20 | 0.51 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.51 |
| ▸ | ENGASE | Q8NFI3 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Omeprazole Sulfone SCHEMBL33721996 | 0.88 | CYP2C9 (0.85) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| Omeprazole Sulfone SCHEMBL29415504 | 0.88 | CYP2C9 (0.85) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| Omeprazole Sulfone SCHEMBL2340649 | 0.88 | CYP2C9 (0.85) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| Omeprazole Sulfone SCHEMBL28015857 | 0.88 | CYP2C9 (0.83) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| SCHEMBL1477733 | 0.87 | CYP2C9 (0.69) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| SCHEMBL27835690 | 0.82 | CYP2C9 (0.63) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| SCHEMBL1907465 | 0.82 | CYP2C9 (0.62) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| SCHEMBL4564707 | 0.81 | CYP2C9 (0.61) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| SCHEMBL8787822 | 0.81 | CYP2C9 (0.61) | CYP2C9BRS3ATP4AATP4BKMT2A | |
| SCHEMBL4564490 | 0.81 | CYP2C9 (0.61) | CYP2C9BRS3ATP4AATP4BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7598273-B2 | Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties | AUSPEX PHARMACEUTICALS, INC (US) | 2009-10-06 | — | — | US | disclosed |
| US-20090215831-A1 | INHIBITORS OF THE GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-08-27 | — | — | US | disclosed |
| US-20090209592-A1 | INHIBITORS OF THE GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-08-20 | — | — | US | disclosed |
| US-20070082929-A1 | Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties | AUSPEX PHARMACEUTICALS, INC. | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209592-A1 | INHIBITORS OF THE GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES | ATP4A, ATP6V1G1, ATP6V1E1 | CYP2C9 2123/4885BRS3 2346/4885ATP4A 1/4885 |
| US-20070082929-A1 | Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties | ATP4A, ATP6V1G1, ATP6V1E1 | CYP2C9 2123/4885BRS3 2346/4885ATP4A 1/4885 |
| US-20090215831-A1 | INHIBITORS OF THE GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES | ATP4A, ATP6V1G1, ATP6V1E1 | CYP2C9 2123/4885BRS3 2346/4885ATP4A 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.